Rosuviron-T Tablet
Marketer
Nvron Life Science Ltd
Salt Composition
Telmisartan (40mg) + Rosuvastatin (20mg)
Overview Rosuviron-T Tablet
Combiflow-HP tablets combine two medications to manage hypertension complicated by elevated cholesterol. Reducing blood pressure mitigates the risk of future strokes and heart attacks. Combiflow-HP may be taken with or without food, consistently at evenly spaced intervals as directed by your physician. Maintaining a regular dosing schedule improves adherence. Treatment duration and dosage vary depending on your specific condition. Complete the prescribed course, even if symptoms improve. Lifestyle modifications, including regular exercise, smoking cessation, and a low-sodium, low-fat diet, enhance treatment efficacy. Common side effects include nausea, abdominal discomfort, constipation, headaches, and myalgia. Drowsiness and vertigo may occur; avoid driving or activities requiring alertness until the effects are known. Report any persistent or bothersome side effects to your doctor. Potassium-rich foods should be limited during treatment. Regular monitoring of blood pressure, glucose, and electrolytes may be required. Inform your doctor of any kidney or liver disease, or severe dehydration before starting treatment. Pregnant or lactating individuals should consult their physician before use. Disclose all other medications to your healthcare provider, as interactions are possible.
Uses of Rosuviron-T Tablet
Elevated blood pressure and hyperlipidemia
Major Benefits of Rosuviron-T Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Rosuviron-T Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Rosuviron-T Tablet:
- Nausea
- Constipation
- Stomach pain
- Headache
- Weakness
- Dizziness
- Muscle pain
- Increased potassium level in blood
- Increased glucose level in blood
- Increased liver enzymes
How to use Rosuviron-T Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rosuviron-T Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Rosuviron-T Tablet works:
Telmisartan and Rosuvastatin, combined in Rosuviron-T tablets, manage elevated blood pressure and cholesterol levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Rosuviron-T Tablet is contraindicated.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Rosuviron-T Tablets. Research in both animals and pregnant women reveals substantial risks to fetal development; consult a physician before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Rosuviron-T Tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rosuviron-T Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Rosuviron-T tablets cautiously, potentially requiring dosage modification under medical supervision. Rosuviron-T tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Rosuviron-T Tablets, as dose modification may be necessary. Consult a physician for guidance. Rosuviron-T Tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Rosuviron-T Tablet :
Should you forget to take a Rosuviron-T Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rosuviron-T Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



